
Join to view full profile
101 Columbian StWeymouth, MA 02190
Phone+1 781-624-5000
Fax+1 781-624-4840
Dr. Gupta is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Pulmonary Disease and Critical Care Medicine, 2017 - 2023
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2015 - 2018
Icahn School of Medicine at Mount Sinai (Bronx)Residency, Internal Medicine, 2015 - 2018
B. J. Medical College AhmedabadClass of 2013
Certifications & Licensure
MA State Medical License 2021 - 2026
RI State Medical License 2021 - 2026
NY State Medical License 2018 - 2020
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 3 citationsEvaluation of the serotonin pathway as a biomarker in cholangiocarcinoma.Christos Fountzilas, Sylvia Alarcon Velasco, Wiam Bshara, Charles M LeVea, Medhavi Gupta
Journal of Gastrointestinal Oncology. 2023-10-31 - 26 citationsLeft sided breast cancer is associated with aggressive biology and worse outcomes than right sided breast cancer.Yara Abdou, Medhavi Gupta, Mariko Asaoka, Kristopher Attwood, Opyrchal Mateusz
Scientific Reports. 2022-08-04 - 13 citationsHealth-Related Quality of Life (HRQoL) in Neuroendocrine Tumors: A Systematic Review.Rohit Gosain, Medhavi Gupta, Arya Mariam Roy, Jonathan Strosberg, Kathryn M Glaser
Cancers. 2022-03-10
Lectures
- A phase II study of trifluridine/tipiracil, irinotecan, and bevacizumab in pretreated metastatic colorectal cancer (TABAsCO).ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020
- Phase II study of nanoliposomal irinotecan (nal-IRI) with 5-fluorouracil (5-FU)/folinic acid (FA) in refractory advanced high-grade neuroendocrine cancer (HG-NEC) of g...ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









